Daniel Brennan
Stock Analyst at TD Cowen
(1.75)
# 1,087
Out of 4,413 analysts
9
Total ratings
54.55%
Success rate
32.04%
Average return
Main Sectors:
Top Industries:
7 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California | Maintains: Buy | $12 → $2.5 | $1.69 | +47.93% | 2 | Apr 17, 2024 | |
LAB Standard BioTools | Initiates: Buy | $3.5 | $2.54 | +37.80% | 1 | Apr 16, 2024 | |
AVTR Avantor | Maintains: Buy | $25 → $29 | $24.42 | +18.76% | 2 | Feb 15, 2024 | |
TMO Thermo Fisher | Maintains: Overweight | $613 → $670 | $574.99 | +16.52% | 1 | Feb 2, 2023 | |
CRL Charles River Laboratories International | Upgrades: Buy | n/a | $232.69 | - | 1 | May 13, 2020 | |
MTD Mettler-Toledo International | Maintains: Neutral | n/a | $1,249.75 | - | 1 | Apr 28, 2020 | |
EXAS Exact Sciences | Maintains: Buy | n/a | $60.01 | - | 1 | Apr 28, 2020 |
Pacific Biosciences of California
Apr 17, 2024
Maintains: Buy
Price Target: $12 → $2.5
Current: $1.69
Upside: +47.93%
Standard BioTools
Apr 16, 2024
Initiates: Buy
Price Target: $3.5
Current: $2.54
Upside: +37.80%
Avantor
Feb 15, 2024
Maintains: Buy
Price Target: $25 → $29
Current: $24.42
Upside: +18.76%
Thermo Fisher
Feb 2, 2023
Maintains: Overweight
Price Target: $613 → $670
Current: $574.99
Upside: +16.52%
Charles River Laboratories International
May 13, 2020
Upgrades: Buy
Price Target: n/a
Current: $232.69
Upside: -
Mettler-Toledo International
Apr 28, 2020
Maintains: Neutral
Price Target: n/a
Current: $1,249.75
Upside: -
Exact Sciences
Apr 28, 2020
Maintains: Buy
Price Target: n/a
Current: $60.01
Upside: -